Compare IFS & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IFS | MMSI |
|---|---|---|
| Founded | 1897 | 1987 |
| Country | Peru | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.9B |
| IPO Year | 2019 | 1990 |
| Metric | IFS | MMSI |
|---|---|---|
| Price | $49.79 | $79.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $48.00 | ★ $106.13 |
| AVG Volume (30 Days) | 205.7K | ★ 795.8K |
| Earning Date | 02-11-2026 | 02-24-2026 |
| Dividend Yield | ★ 1.88% | N/A |
| EPS Growth | ★ 81.66 | N/A |
| EPS | ★ 5.02 | 1.95 |
| Revenue | ★ $1,581,287,530.00 | $1,477,128,000.00 |
| Revenue This Year | N/A | $13.67 |
| Revenue Next Year | $3.75 | $6.16 |
| P/E Ratio | ★ $10.12 | $41.25 |
| Revenue Growth | ★ 33.10 | 11.41 |
| 52 Week Low | $29.09 | $78.12 |
| 52 Week High | $52.58 | $110.67 |
| Indicator | IFS | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 70.36 | 38.14 |
| Support Level | $47.63 | $79.38 |
| Resistance Level | $52.58 | $82.28 |
| Average True Range (ATR) | 1.60 | 1.94 |
| MACD | 0.21 | -0.20 |
| Stochastic Oscillator | 64.78 | 5.91 |
Intercorp Financial Services Inc is a provider of banking, insurance, wealth management services and payments for retail customers and commercial clients in Peru. The company has four operating segments; the Banking segment includes Mainly loans, credit facilities, deposits, and current accounts, the Insurance segment provides life annuity products with single-premium payment and conventional life insurance products and other retail insurance products, the Wealth Management segment provides brokerage and investment management services. Its geographical segments include Peru and Panama.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.